To submit an unsolicited request for medical information regarding Madrigal’s research or data, please complete this form.

Corporate Headquarters

Madrigal is a clinical-stage biopharmaceutical company developing a potential first-to-market novel therapy for patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis.

Learn More